Article Contents ::
- 1 Details About Generic Salt :: Loratadi
- 2 Main Medicine Class:: Antihistamine
- 3 (lore-AT-uh-DEEN) Claritin Tablets: 10 mg, Tablets, rapidly disintegrating: 10 mg, Syrup: 1 mg/mL Class: Antihistamine
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Loratadi
Main Medicine Class:: Antihistamine
(lore-AT-uh-DEEN)
Claritin
Tablets: 10 mg, Tablets, rapidly disintegrating: 10 mg, Syrup: 1 mg/mL
Class: Antihistamine
Drugs Class ::
Action Competitively antagonizes histamine at the H1-receptor site.
Indications for Drugs ::
Indications Symptomatic relief (nasal and nonnasal) of symptoms associated with seasonal allergic rhinitis; treatment of chronic idiopathic urticaria.
Drug Dose ::
Route/Dosage
ADULTS and CHILDREN ³ 6 yr: PO 10 mg once daily.
CHILDREN 2 to 5 yr: PO 5 mg once daily.
Hepatic Impairment
ADULTS and CHILDREN ³ 6 yr: PO Start with 10 mg every other day.
CHILDREN 2 to 5 yr: PO Start with 5 mg every other day.
Renal Impairment (GFR < 30 mL/min):
ADULTS and CHILDREN ³ 6 yr: PO Start with 10 mg every other day.
CHILDREN 2 to 5 yr: PO Start with 5 mg every other day.
Contraindication ::
Contraindications Hypersensitivity to antihistamines; use in nursing women.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children < 12 yr. Hepatic Impairment: Use drug with caution in patients with hepatic impairment. Hypersensitivity: Hypersensitivity may occur.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CARDIOVASCULAR: Hypotension; hypertension; palpitations; tachycardia. CNS: Hyperkinesia; paresthesia; dizziness; migraine; tremor; vertigo; headache; somnolence; fatigue. DERMATOLOGIC: Dermatitis; dry hair; dry skin; urticaria; rash; pruritus; purpura; photosensitivity. EENT: Conjunctivitis; blurred vision; earache; eye pain; blepharospasm; dysphonia; altered taste. GI: Anorexia; increased appetite and weight gain; nausea; vomiting; diarrhea; constipation; flatulence; gastritis; dyspepsia; dry mouth. GU: Urinary discoloration; altered micturation; menstrual irregularities. RESPIRATORY: Nasal dryness; pharyngitis; epistaxis; nasal congestion; dyspnea; coughing; rhinitis; hemoptysis; sinusitis; sneezing; bronchospasm; bronchitis; laryngitis. OTHER: Breast pain; arthralgia; myalgia.
Drug Mode of Action ::
Action Competitively antagonizes histamine at the H1-receptor site.
Drug Interactions ::
Interactions
Alcohol, CNS depressants: Additive CNS depressant effects.
Azole Antifungals (eg, ketoconazole, itraconazole): Use of these agents with similar antihistamines has resulted in serious cardiac toxicity, including death.
Food: May increase absorption of loratadine.
MAO Inhibitors: Concomitant use may prolong and intensify anticholinergic effects of loratadine and may result in hypotensive episodes.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies, especially to antihistamines.
- Obtain baseline BP, respirations, and pulse before beginning therapy.
- Monitor closely for signs of hypersensitivity if patient has history of allergic reactions to other antihistamines.
- Observe for dizziness, excessive sedation, syncope, confusion, and hypotension, especially in elderly patients.
|
Drug Storage/Management ::
Administration/Storage
- Administer on empty stomach 1 hr before or 2 hr after eating.
- Store at room temperature.
Drug Notes ::
Patient/Family Education
- Warn patient not to increase dose to obtain quicker relief of symptoms.
- If patient is to have allergy skin testing, advise to avoid taking medication for 4 days before test.
- Tell patient that drug may be used alone for symptoms of sneezing and runny nose with slight nasal congestion.
- Advise patient not to take any otc medications without consulting health care provider.
- Instruct patient to maintain fluid intake of 1½ to 2 quarts/day to decrease viscosity of secretions.
- Caution patient to avoid exposure to sunlight and to use sunscreen or wear protective clothing to avoid photosensitivity reaction.
- Instruct patient to avoid intake of alcoholic beverages or other CNS depressants (eg, sedatives, hypnotics, tranquilizers).
- Advise patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness until response to medication is known.
- Explain that rapidly disintegrating tablet will disintegrate on the tongue and may be administered with or without water.
–>